David Dai
Stock Analyst at UBS
(0)
# 5038
Out of 5,370 analysts
26
Total ratings
15.79%
Success rate
-29.56%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BPMC Blueprint Medicines | Maintains: Neutral | 88 129 | 128.09 | 0.71% | 2 | Jun 5, 2025 | |
IOVA Iovance Biotherapeut... | Downgrades: Neutral | 17 2 | 2.1 | -4.76% | 2 | May 16, 2025 | |
CGEM Cullinan Therapeutic... | Maintains: Buy | 30 24 | 8.75 | 174.29% | 2 | May 12, 2025 | |
NUVL Nuvalent | Upgrades: Buy | 100 100 | 76.36 | 30.96% | 2 | Mar 14, 2025 | |
KURA Kura Oncology | Maintains: Buy | 27 14 | 6.48 | 116.05% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sell | 24 | 32.63 | -26.45% | 1 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | 3.62 | 452.49% | 1 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 35 | 11.87 | 194.86% | 1 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 72 | 53.25 | 35.21% | 1 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 69 | 23.59 | 192.5% | 1 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 50 | 22.4 | 123.21% | 1 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 60 | 25.41 | 136.13% | 1 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 37 | 9.97 | 271.11% | 1 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 28 | 0.71 | 3843.66% | 1 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 40 | 14.62 | 173.6% | 1 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 40 | 1.5 | 2566.67% | 1 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 50 | 1.89 | 2545.5% | 1 | Nov 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 41 52 | 33.45 | 55.46% | 1 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 41 | n/a | n/a | 1 | Apr 25, 2017 |